Int J Radiat Oncol Biol Phys

• 

  Publication Venue For

  • We need better figures!.  88:236. 2014
  • ABR examinations: the why, what, and how..  87:237-245. 2013
  • A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning..  87:176-181. 2013
  • In regard to Shah..  86:596. 2013
  • Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agents..  86:136-142. 2013
  • Oncology scan-treatment, consequences, and genomics in gastrointestinal cancer..  86:1-3. 2013
  • Validating a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer..  85:953-958. 2013
  • Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials..  85:271-277. 2013
  • Reproducibility of tumor motion probability distribution function in stereotactic body radiation therapy of lung cancer..  84:861-866. 2012
  • A quality assurance method that utilizes 3D dosimetry and facilitates clinical interpretation..  84:540-546. 2012
  • Evaluation of the accuracy of a 3D surface imaging system for patient setup in head and neck cancer radiotherapy..  84:547-552. 2012
  • In Reply to O'Sullivan et al..  84:307-308. 2012
  • Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy..  83:1126-1131. 2012
  • Local failure in resected N1 lung cancer: implications for adjuvant therapy..  83:727-733. 2012
  • Global reluctance to practice evidence-based medicine continues in the treatment of uncomplicated painful bone metastases despite level 1 evidence and practice guidelines..  83:1-2. 2012
  • Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007..  82:e781-e786. 2012
  • Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field map..  82:1584-1593. 2012
  • The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer..  82:1872-1879. 2012
  • The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection..  82:e773-e779. 2012
  • Volumetric-modulated arc therapy: effective and efficient end-to-end patient-specific quality assurance..  82:1567-1574. 2012
  • Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters..  82:e345-e350. 2012
  • A polymorphism within the promoter of the TGFβ1 gene is associated with radiation sensitivity using an objective radiologic endpoint..  82:e247-e255. 2012
  • FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism..  82:321-326. 2012
  • Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists..  81:e775-e780. 2011
  • Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma..  81:654-659. 2011
  • Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors..  81:812-818. 2011
  • Teaching the anatomy of oncology: evaluating the impact of a dedicated oncoanatomy course..  79:853-859. 2011
  • Digital tomosynthesis for respiratory gated liver treatment: clinical feasibility for daily image guidance..  79:289-296. 2011
  • Proteomic analysis of radiation-induced changes in rat lung: Modulation by the superoxide dismutase mimetic MnTE-2-PyP(5+)..  78:547-554. 2010
  • Impact of volumetric modulated arc therapy technique on treatment with partial breast irradiation..  78:288-296. 2010
  • The beginning of a new journal..  78:1-2. 2010
  • An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control..  77:843-850. 2010
  • Biologically effective dose (BED) correlation with biochemical control after low-dose rate prostate brachytherapy for clinically low-risk prostate cancer..  77:139-146. 2010
  • Radiosensitization of chemotherapy-refractory, locally advanced or locally recurrent breast cancer with trastuzumab: a phase II trial..  76:998-1004. 2010
  • Imaging for assessment of radiation-induced normal tissue effects..  76:S140-S144. 2010
  • Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes..  76:935-942. 2010
  • Regional lung density changes after radiation therapy for tumors in and around thorax..  76:116-122. 2010
  • Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer..  75:1462-1467. 2009
  • Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment..  75:1596-1604. 2009
  • Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer..  75:725-733. 2009
  • Dynamic MRI of grid-tagged hyperpolarized helium-3 for the assessment of lung motion during breathing..  75:276-284. 2009
  • American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments..  74:1311-1318. 2009
  • Accelerated partial breast irradiation: caution and concern from an ASTRO task force..  74:981-984. 2009
  • ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate..  74:667-672. 2009
  • Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer..  74:377-382. 2009
  • Elective nodal irradiation for locally advanced non-small-cell lung cancer: it's called cancer for a reason..  73:1291-1292. 2009
  • Stereotactic body radiotherapy for lesions of the spine and paraspinal regions..  73:1369-1375. 2009
  • Comparing digital tomosynthesis to cone-beam CT for position verification in patients undergoing partial breast irradiation..  73:952-957. 2009
  • Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors..  73:659-664. 2009
  • The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer..  73:935-943. 2009
  • Quantifying the dosimetric trade-offs when using intensity-modulated radiotherapy to treat concave targets containing normal tissues..  73:585-593. 2009
  • Clinical evaluation of positioning verification using digital tomosynthesis and bony anatomy and soft tissues for prostate image-guided radiotherapy..  73:296-305. 2009
  • Reproducibility of interfraction lung motion probability distribution function using dynamic MRI: statistical analysis..  72:1228-1235. 2008
  • Adaptive stereotactic body radiation therapy planning for lung cancer. 2013
  • Lymphocyte predominance Hodgkin’s disease: High cure rate and acceptable complication rate with conventional treatment